Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

443
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
443
Development of Immunocompetence01:22

Development of Immunocompetence

482
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
482
Vaccinations01:51

Vaccinations

45.6K
Overview
45.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

286
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
286
Cancer Vaccines01:30

Cancer Vaccines

542
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
542

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bovine Lymphocyte Intestinal Retention Defect (BLIRD): a novel recessive immunogenetic disorder in Holstein cattle.

The veterinary quarterly·2025
Same author

Ageing-driven molecular and functional changes in the bovine endometrium.

PloS one·2025
Same author

The bacterial faecal microbiota shifts during the transition period in dairy cows.

Animal microbiome·2025
Same author

The Epstein-Barr virus EBNA1 protein binds to G-quadruplexes in its own mRNA hence controlling its expression and immune evasion of the virus.

Nucleic acids research·2025
Same author

Influenza A virus in dairy cattle: infection biology and potential mammary gland-targeted vaccines.

NPJ vaccines·2025
Same author

Expression of FcμR by bovine mononuclear blood leukocytes.

Developmental and comparative immunology·2024
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Oct 2, 2025

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-&kappa;B Reporter Transgenic
08:51

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Published on: September 4, 2012

19.4K

Progress towards the Elusive Mastitis Vaccines.

Pascal Rainard1, Florence B Gilbert1, Rodrigo P Martins1

  • 1ISP, INRAE, Université de Tours, UMR1282, 37380 Nouzilly, France.

Vaccines
|February 26, 2022
PubMed
Summary
This summary is machine-generated.

Current mastitis vaccines in dairy farming are ineffective due to mammary gland immunobiology and pathogen adaptation. Future vaccines require novel approaches, potentially involving cell-mediated immunity and improved vaccinology strategies for better udder protection.

Keywords:
cattlecell-mediated immunityhumoral immunitymastitisvaccine

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.9K

Related Experiment Videos

Last Updated: Oct 2, 2025

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-&kappa;B Reporter Transgenic
08:51

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Published on: September 4, 2012

19.4K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.9K

Area of Science:

  • Veterinary immunology
  • Dairy science
  • Vaccinology

Background:

  • Mastitis poses a significant challenge in dairy farming, necessitating reduced antibiotic use.
  • Current vaccines for mastitis prevention exhibit unsatisfactory efficacy.
  • Bacterial infections in the mammary gland are common, with frequent recurrences.

Purpose of the Study:

  • To review the reasons behind the limited effectiveness of current mastitis vaccines.
  • To identify key areas for research to improve mastitis vaccine development.
  • To propose novel strategies for eliciting protective immunity against mammary infections.

Main Methods:

  • Review of existing literature on mastitis immunobiology and vaccinology.
  • Analysis of pathogen adaptation to the mammary gland niche.
  • Exploration of immune mechanisms beyond those induced by natural infection.

Main Results:

  • Shortcomings of current vaccines are linked to mammary gland-specific immune responses and pathogen adaptations.
  • Natural infection does not confer sterilizing immunity, leading to recurrent mastitis.
  • Efficacious vaccines must induce immune responses superior to those from natural infection.

Conclusions:

  • Improving mastitis vaccines requires addressing mammary gland immunobiology and pathogen adaptation.
  • Focusing on cell-mediated immunity, particularly T cell interactions with mammary epithelium, is a promising avenue.
  • Advances in vaccinology, including adjuvant use, administration routes, and delivery systems, are crucial for success.